mTOR signalling and cellular metabolism are mutual determinants in cancer

D Mossmann, S Park, MN Hall - Nature Reviews Cancer, 2018 - nature.com
Oncogenic signalling and metabolic alterations are interrelated in cancer cells. mTOR,
which is frequently activated in cancer, controls cell growth and metabolism. mTOR …

Role of tumor and host autophagy in cancer metabolism

L Poillet-Perez, E White - Genes & development, 2019 - genesdev.cshlp.org
Macroautophagy (referred to here as autophagy) degrades and recycles cytoplasmic
constituents to sustain cellular and mammalian metabolism and survival during starvation …

Autophagy maintains tumour growth through circulating arginine

L Poillet-Perez, X Xie, LE Zhan, Y Yang, DW Sharp… - Nature, 2018 - nature.com
Autophagy captures intracellular components and delivers them to lysosomes, where they
are degraded and recycled to sustain metabolism and to enable survival during starvation …

[HTML][HTML] Arginine metabolism and deprivation in cancer therapy

S Zou, X Wang, P Liu, C Ke, S Xu - Biomedicine & Pharmacotherapy, 2019 - Elsevier
Highlights•Reviewed the function of arginine and its metabolites in arginine deprivation
therapy.•Discussed the difference of arginine deiminase and recombinant human arginase …

Combination of an autophagy inducer and an autophagy inhibitor: a smarter strategy emerging in cancer therapy

T Liu, J Zhang, K Li, L Deng, H Wang - Frontiers in pharmacology, 2020 - frontiersin.org
Autophagy is considered a cytoprotective function in cancer therapy under certain conditions
and is a drug resistance mechanism that represents a clinical obstacle to successful cancer …

Blocking CD47 efficiently potentiated therapeutic effects of anti-angiogenic therapy in non-small cell lung cancer

X Zhang, Y Wang, J Fan, W Chen, J Luan, X Mei… - … for immunotherapy of …, 2019 - Springer
Background Inhibitors targeting VEGF and VEGFR are commonly used in the clinic, but only
a subset of patients could benefit from these inhibitors and the efficacy was limited by …

[HTML][HTML] SR9009 induces a REV-ERB dependent anti-small-cell lung cancer effect through inhibition of autophagy

W Shen, W Zhang, W Ye, H Wang, Q Zhang, J Shen… - Theranostics, 2020 - ncbi.nlm.nih.gov
Rationale: The circadian clock coordinates cell proliferation and metabolism and impacts the
progression of some diseases, particularly cancer. Pharmacological modulation of the …

LncRNA KTN1-AS1 promotes the progression of non-small cell lung cancer via sponging of miR-130a-5p and activation of PDPK1

C Li, W Zhao, X Pan, X Li, F Yan, S Liu, J Feng, J Lu - Oncogene, 2020 - nature.com
Non-small cell lung cancer (NSCLC) is the major cause of cancer-associated death
worldwide, but its underlying mechanisms remain to be fully elucidated. Long noncoding …

Targeting the HGF/MET axis in cancer therapy: challenges in resistance and opportunities for improvement

X Huang, E Li, H Shen, X Wang, T Tang… - Frontiers in Cell and …, 2020 - frontiersin.org
Among hundreds of thousands of signal receptors contributing to oncogenic activation,
tumorigenesis, and metastasis, the hepatocyte growth factor (HGF) receptor–also called …

Arginine deprivation as a strategy for cancer therapy: An insight into drug design and drug combination

Y Zhang, SF Chung, SY Tam, YC Leung, X Guan - Cancer Letters, 2021 - Elsevier
Extensive studies have shown that cancer cells have specific nutrient auxotrophy and thus
have much a higher demand for certain nutrients than normal cells. Amino acid deprivation …